B-cell-activating factor and autoimmune myasthenia gravis.
about
Elevated serum levels of visfatin in patients with henoch-schönlein purpura.Myasthenia gravis: an update for the clinician.Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis.Immunogenicity of therapeutic proteins: influence of aggregation.Regulatory B Cells in Seropositive Myasthenia Gravis versus Healthy Controls.New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis
P2860
B-cell-activating factor and autoimmune myasthenia gravis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
B-cell-activating factor and autoimmune myasthenia gravis.
@en
type
label
B-cell-activating factor and autoimmune myasthenia gravis.
@en
prefLabel
B-cell-activating factor and autoimmune myasthenia gravis.
@en
P2860
P356
P1433
P1476
B-cell-activating factor and autoimmune myasthenia gravis.
@en
P2093
Robert P Lisak
Samia Ragheb
P2860
P304
P356
10.4061/2011/939520
P577
2011-11-28T00:00:00Z